Question

Shown below is certain data for the Buyer and Target firms. Buyer   Target Standalone value $1,200  ...

Shown below is certain data for the Buyer and Target firms.

Buyer   Target
Standalone value $1,200   $ 300
Shares Outstanding   10   50

Buyer estimates the present value of synergies as $100. Buyer makes an all cash offer $450 for the stock of Target.

Calculate:

The gain for buyer (deal NPV)

The gain for the target (deal NPV)

Buyer's post-acquisition stock price per share

Homework Answers

Answer #1

Standalone total value of buyer and target firm is 1200+ 300 (1500). They expect a synergy of 100 that would take the combined value to 1600 NPV.

Buyer makes an all cash offer of 450. If we assume this cash offer will be made by the buyer from its existing business only then 450 would be reduced from the value of existing business, 300(Value of Firm B) would be added to the value , plus synergy of 100 would be added.

Hence, post deal NPV of buyer is 1200 + 300 +100 -450 = 1150

Target Firm would receive 450

Gain for buyer = NPV after takeover - NPV before takeover = 1200 - 1150 = -50

Gain for Target= NPV after takeover - NPV before takeover = 450 - 300 = 150

Buyer post acquisition stock price = NPV after takeover / Number of shares = 1150 / 10 = 115  

Know the answer?
Your Answer:

Post as a guest

Your Name:

What's your source?

Earn Coins

Coins can be redeemed for fabulous gifts.

Not the answer you're looking for?
Ask your own homework help question
Similar Questions
Green Rice Smartphone Inc. plans to acquire CCA Technologies Inc. Assume that both firms have no...
Green Rice Smartphone Inc. plans to acquire CCA Technologies Inc. Assume that both firms have no debts outstanding. Before the acquisition, CCA’s share price is $16 and there are 1,000 shares outstanding. Green Rice’s share price is $25 and there are 1,500 shares outstanding. Green Rice has estimated that, after the acquisition, its annual cash flow will increase by $1,200 permanently. The discount rate of the combined firm will be 10%. Green Rice is thinking about two acquisition offers: Cash...
An acquirer has an issued capital of 300 million shares trading at $6.01. A target company...
An acquirer has an issued capital of 300 million shares trading at $6.01. A target company has an issued capital of 500 million shares trading at $2.95. The acquirer expects synergies from an acquisition with a present value of $300 million and offers target company shareholders 0.5 acquirer shares for each target company share. What is the likely post-announcement price of target company stock (to two decimal places)?
An acquirer has an issued capital of 300 million shares trading at $6. A target company...
An acquirer has an issued capital of 300 million shares trading at $6. A target company has an issued capital of 500 million shares trading at $3.04. The acquirer expects synergies from an acquisition with a present value of $300 million and offers target company shareholders 0.49 acquirer shares for each target company share. What is the likely post-announcement price of target company stock (to two decimal places)?
An acquirer has an issued capital of 300 million shares trading at $6.16. A target company...
An acquirer has an issued capital of 300 million shares trading at $6.16. A target company has an issued capital of 500 million shares trading at $3.05. The acquirer expects synergies from an acquisition with a present value of $200 million. What is the maximum exchange ratio (to two decimal places) that could be offered in a stock swap and still generate a positive-NPV for the acquirer?
Consider the following premerger information about a bidding firm (Firm B) and a target firm (Firm...
Consider the following premerger information about a bidding firm (Firm B) and a target firm (Firm T). Assume that both firms have no debt outstanding. Firm B Firm T   Shares outstanding 4,800 1,200   Price per share $ 44 $ 16    Firm B has estimated that the value of the synergistic benefits from acquiring Firm T is $8,900. Firm T can be acquired for $18 per share in cash or by exchange of stock wherein B offers one of its...
Given the following info, I created a trial balance (also shown below): Karen Noonan opened Kingbird...
Given the following info, I created a trial balance (also shown below): Karen Noonan opened Kingbird Inc. on February 1, 2017. During February, the following transactions were completed: Feb. 1 Issued 4,400 shares of Kingbird common stock for $13,260. Each share has a $1.50 par. 1 Borrowed $8,000 on a 2-year, 6% note payable. 1 Paid $9,200 to purchase used floor and window cleaning equipment from a company going out of business ($4,440 was for the floor equipment and $4,760...
1- Many U.S. firms with a large percentage of their revenues derived in foreign countries prefer...
1- Many U.S. firms with a large percentage of their revenues derived in foreign countries prefer to leave their cash outside the United States because using those funds to pay dividends or purchase treasury stock would Select one: a. promote foreign investment. b. require a big U.S. corporate income tax payment. c. create pressure for decreased exporting. d. decrease foreign exchange. e. inflate stock prices. 2- In projected financial statements, what is used as a plug figure? Select one: a....
Please read the article and answear about questions. Determining the Value of the Business After you...
Please read the article and answear about questions. Determining the Value of the Business After you have completed a thorough and exacting investigation, you need to analyze all the infor- mation you have gathered. This is the time to consult with your business, financial, and legal advis- ers to arrive at an estimate of the value of the business. Outside advisers are impartial and are more likely to see the bad things about the business than are you. You should...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly O'Brien, David Roberts, and Barbara Smalley. O'Brien and Roberts, both MDs, were on the research faculty at the Chicago Medical School at the time; O'Brien specialized in biochemistry and molecular biology, and Roberts specialized in immunology and medical microbiology. Smalley, who has a PhD, served a department chair of the Microbiology Department at the same school. The company started as a research and development...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly...
Illinois Bio Technologies Illinois Bio Technologies (IBTECH) was founded in Rosemont, Illinois, in 1992 by Kelly O'Brien, David Roberts, and Barbara Smalley. O'Brien and Roberts, both MDs, were on the research faculty at the Chicago Medical School at the time; O'Brien specialized in biochemistry and molecular biology, and Roberts specialized in immunology and medical microbiology. Smalley, who has a PhD, served a department chair of the Microbiology Department at the same school. The company started as a research and development...
ADVERTISEMENT
Need Online Homework Help?

Get Answers For Free
Most questions answered within 1 hours.

Ask a Question
ADVERTISEMENT